Shire Pharmaceuticals Acquires Lotus Tissue Repair for Undisclosed Sum

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=757a8151-ac2d-4e1a-8564-d196eee86d97&Preview=1
Date
1/9/2013
Company Name
Lotus Tissue Repair
Mailing Address
One Mifflin Place Cambridge, MA 02138
Company Description
Lotus Tissue Repair is developing its proprietary recombinant human collagen Type VII (rC7) technology as a treatment for dermatologic conditions in which rC7 may play an important role in accelerating chronic wound healing, such as diabetic foot ulcers, venous stasis ulcers and similar conditions.
Website
http://www.lotustissuerepair.com
Transaction Type
M&A
Transaction Amount
Undisclosed
Transaction Round
Proceeds Purposes
M&A Terms
Shire will purchase the company for an upfront payment and certain contingent payments based on the achievement of certain safety and development milestones.